MedTrace Logo

Comparisons of the Therapeutic Effects of Dienogest and Danazol on Endometriosis

NCT05697471 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-03-29

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy between dienogest and danazol.

Conditions

  • Endometriosis

Interventions

DRUG

Dienogest

Dienogest 2 mg per day

DRUG

Danazol

Danzol 200MG per day

Sponsors & Collaborators

  • Far Eastern Memorial Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-25
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05697471 on ClinicalTrials.gov